Camp4 Therapeutics Corporation (CAMP)

NASDAQ: CAMP · USD

$3.63

-0.02 (-0.6%)· Recorded snapshot

Market cap	227.8M
Revenue (ttm)	4.2M
Net income (ttm)	-107.2M
EPS (ttm)	-$2.18
Shares out	62.8M
Volume	80,471
Beta	0.26

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 4.2M
Net income (ttm): -107.2M
EPS (ttm): -$2.18
Market cap: 227.8M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Mantener

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 13.4P50 20.2P75 35.7

Trailing P/En/a

P25 15.4P50 25.8P75 43.5

ROE-545.9

P25 -113.8P50 -46.5P75 -0.9

ROIC-133.9

P25 -68.5P50 -27.1P75 1.8

Benchmarks · 1M

All CAMP indicators

Market & fundamental data

Available fields

183

Groups with data

Currency

USD

Showing 183 of 183 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001736730
Company name	Camp4 Therapeutics Corporation
Country	United States
Country code	US
CUSIP number	13463J101
Earnings date	2026-11-09
Earnings time	amc
Employees	48
Employees change	-7
Employees growth	-12.73%
Enterprise value	$143.8M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2016
In index	RUSSELL2000
Industry	Biotechnology
IPO date	2024-10-11
Is primary listing	Yes
Is SPAC	No
ISIN number	US13463J1016
Last 10-K release date	2026-03-05
Last earnings date	2026-08-13
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$227.8M
Market cap category	Micro-Cap
Next earnings date	2026-11-09
Options	No
Price	$3.63
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	CAMP
U.S. state	Massachusetts
Website	https://www.camp4tx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-59.97%
EV/Sales	33.65x
FCF / EV yield	-20.24%
FCF yield	-12.71%
Forward EV/Sales	18.37x
Forward P/S	29.25x
P/S ratio	53.58x
Sector forward P/E	23.56x
Sector P/E	50.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Operating margin	-1,242.5%
Pretax margin	-2,543.74%
Profit per employee	$-2.2M
Revenue per employee	$87,833
ROA	-45.25%
ROCE	-70.52%
ROE	-545.85%
ROIC	-133.94%
SBC / revenue	131.36%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	2
EPS growth years	2
Net income growth years	0
Revenue growth	40.21%
Revenue growth (Q)	18.84%
Revenue growth (QoQ)	37.48%
Revenue growth quarters	2
Revenue growth years	2

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-129,000
Depreciation and amortization	$1.8M
EBIT	$-52.4M
EBITDA	$-50.6M
EPS	$-2.18
FCF per share	$-0.46
Financing cash flow	$76M
Free cash flow	$-28.7M
Free cash flow minus SBC	$-34.3M
Gross profit	$-34.5M
Investing cash flow	$-93,000
Net borrowing	$-129,000
Net cash flow	$47.3M
Net income	$-107.2M
Operating cash flow minus SBC	$-34.1M
Operating income	$-52.4M
Revenue	$4.2M
Stock-based compensation	$5.5M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-4.9
Book value per share	$-0.01
Long-term assets	$3.4M
Long-term liabilities	$75M
Net cash (debt)	$84M
Net cash / market cap	37.19%
Net cash growth	163.98%
Piotroski F-Score	2
Property, plant and equipment	$2.4M
Shareholders' equity	$-693,000
Tangible book value	$-693,000
Tangible book value per share	$-0.01
Total assets	$93.4M
Total cash	$86.4M
Total debt	$2.4M
Total liabilities	$94.1M
WACC	5.63%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.06
Current assets	$90M
Current liabilities	$19.1M
Current ratio	4.7
Net working capital	$-14.7M
Quick ratio	4.52
Working capital	$70.9M
Working capital turnover	0.08

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-239.08%
Dividend yield	0%
Shareholder yield	-239.08%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$4.12
1D price change	-0.55%
1M price change	-7.4%
1M total return	-7.4%
1W price change	14.87%
1W total return	14.87%
1Y price change	-6.92%
1Y return CAGR	-6.93%
1Y total return	-6.92%
20-day SMA	$3.55
200-day SMA	$4.24
3M price change	6.14%
3M total return	6.14%
50-day SMA	$3.92
50-day SMA vs 200-day SMA	50under200
52-week high	$7.75
52-week high date	2026-03-09
52-week low	$2.90
52-week low date	2026-07-24
6M price change	-18.24%
6M total return	-18.24%
All-time high	$12.30
All-time high date	2024-10-14
All-time low	$1.31
All-time low date	2025-06-20
Average true range (ATR)	$0.29
Average volume	252.7K
Beta (1Y)	2.42
Beta (2Y)	2.03
Beta (5Y)	0.26
Change from 52-week high	-53.16%
Change from 52-week low	25.17%
Change from all-time high	-70.49%
Change from all-time low	178.16%
Change from open	0.83%
Day's gap	-1.37%
Dollar volume	$292,110
High price	$3.65
Low price	$3.58
Monthly RSI	40.07
Open price	$3.60
Position in 52-week range	71.43%
Premarket change	-15.07%
Premarket close	$3.65
Premarket price	$3.10
Premarket volume	503
Previous close	$3.65
Price vs 150-day SMA	-11.91%
Price vs 20-day SMA	2.2%
Price vs 200-day SMA	-14.41%
Price vs 50-day SMA	-7.3%
Relative volume	0.32
Return from IPO open	-67.74%
Return from IPO price	-67.27%
RSI	50.36
Sharpe ratio	0.41
Sortino ratio	0.77
Volume	80.5K
Weekly RSI	45.78
YTD price change	-40.78%
YTD total return	-40.78%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	43.3M
Float percentage	69.05%
Shares change (QoQ)	0.01%
Shares change (YoY)	239.08%
Shares held by insiders	1.19%
Shares held by institutions	53.4%
Shares outstanding	62.8M
Short % of float	3.37%
Short % of shares	2.33%
Short ratio	5.3 days

Deeper analysis on CAMP

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this CAMP report

Is a complete CAMP research report available?

No complete published report is available for Camp4 Therapeutics Corporation (CAMP) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Camp4 Therapeutics Corporation (CAMP)

Price

Financial snapshot

Fair-value bridge

Latest news · CAMP

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CAMP indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on CAMP

Frequently asked questions